Oxytocin or Galantamine Versus Placebo for the Treatment of Negative Symptoms and Cognitive Impairments in Schizophrenia

NCT01012167 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

86

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Oxytocin
DRUG: Galantamine
OTHER: Placebo-Oxytocin
OTHER: Placebo-Galantamine

Sponsor

University of Maryland, Baltimore

Collaborators

[object Object]